Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shuanghe Decoction (Shuanghe Tang) is a Traditional Chinese Medicine (TCM) herbal formula used to treat conditions characterized by the 'intertwinement of phlegm and blood stasis.' It is a complex mixture formed by the combination of two other classic TCM formulas: Tao Hong Si Wu Tang (composed of Prunus persica, Carthamus tinctorius, Rehmannia glutinosa, Angelica sinensis, Paeonia lactiflora, and Ligusticum chuanxiong) and Er Chen Tang (composed of Pinellia ternata, Citrus reticulata, Poria cocos, and Glycyrrhiza uralensis). In clinical research, particularly in studies led by Jun Li, it has been evaluated as an adjunctive therapy to conventional Western medicine for the treatment of unstable angina pectoris. The formula is intended to improve myocardial ischemia by promoting blood circulation and resolving phlegm-dampness.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shuanghe decoction.